%PDF-1.3
%
4 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
xͱ ᝧ8l+#XP|wźI@B-EFb]VvzP lgsAGN%ҊR
Ӗ
K'd'F"6w
#qV_ִƶS?])u
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
xͱ ᝧ8l+#XP|wźI@B-EFb]VvzP lgsAGN%ҊR
Ӗ
K'd'F"6w
#qV_ִƶS?])u
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
xͱ ᝧ8l+#XP|wźI@B-EFb]VvzP lgsAGN%ҊR
Ӗ
K'd'F"6w
#qV_ִƶS?])u
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
xͱ ᝧ8l+#XP|wźI@B-EFb]VvzP lgsAGN%ҊR
Ӗ
K'd'F"6w
#qV_ִƶS?])u
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 132>>stream
xͱ ᝧ8l+#XP|wźI@B-EFb]VvzP lgsAGN%ҊR
Ӗ
K'd'F"6w
#qV_ִƶS?])u
endstream
endobj
8 0 obj
<>stream
2018-10-24T06:42:19+05:30
Arbortext Advanced Print Publisher 9.0.114/W
2018-10-27T00:43:29-07:00
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
application/pdf
MAB-2018-0030-ver9-Furusawa_2P 233..237
uuid:7948b11b-e983-4190-a91b-ee7dbcde6727
uuid:e130bc12-8d47-4c40-bd77-e2e12c24217f
endstream
endobj
9 0 obj
<>stream
x+ |
endstream
endobj
10 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
11 0 obj
<>stream
x+ |
endstream
endobj
12 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
13 0 obj
<>stream
x+ |
endstream
endobj
14 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
15 0 obj
<>stream
x+ |
endstream
endobj
16 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
17 0 obj
<>stream
x+ |
endstream
endobj
18 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
20 0 obj
<>stream
/GS1 gs
BT
/F3 1 Tf
9.843 0 0 9.843 62.022 725.1588 Tm
0 0 0 rg
0 Tc
0 Tw
[(wa)18.8(s)-317.7(c)0(u)19.7(l)0(t)20.6(u)0(r)20.9(e)0(d)-308.6(i)0(n)-301.8(D)0(M)19.1(E)0(M)-303.8(m)0(e)18.4(d)0(i)14.9(u)0(m)-302.9(\()0(N)20(a)0(c)18.5(a)0(l)19.5(a)0(i)-308.8(T)0(e)18.5(s)0(q)21(u)0(e)19.7(,)-314.4(In)20.9(c.)17.3(\))-312.1(s)0(u)15.3(p)0(-)]TJ
0 -1.1174 TD
[(pl)20.7(em)18.5(en)19.7(te)19.6(d)-588.6(w)0(i)19.8(t)0(h)-572.5(1)0(0)20.8(%)-583.9(he)19.7(at)13.8(-i)20.7(na)19.7(ct)19.5(iv)20.7(at)19.5(ed)-573.6(fe)14(ta)19.6(l)-583(b)0(o)20.8(v)0(i)20.7(n)0(e)-579.3(s)0(e)19.9(r)0(u)20.9(m)]TJ
0 -1.1116 TD
-.0204 Tc
[(\()-20.4(F).6(B)-20.4(S)-.4(;)-361.4(T)-20.4(he)-20.4(rm)-20.4(o)-352.1(F)-20.4(is)-20.4(he)-20.4(r)-352(S)-20.4(ci)-20.4(en)-20.4(t)-5.5(i)-20.4(c)-20.4(,)-348.6(I)-20.4(nc)-20.4(\),)-363.7(1)-20.4(0).4(0)-361.3(u)-20.4(ni)-20.4(ts)-20.4(/m)-20.4(L)-353.3(o)-20.4(f)-345.1(p)-20.4(e)-6.5(n)-20.4(i-)]TJ
T*
0 Tc
[(ci)19.5(ll)20.6(in)15(,)-343.2(1)0(0)20.8(0)]TJ
/F7 1 Tf
4.2449 0 TD
(m)Tj
/F3 1 Tf
.5414 0 TD
[(g/)20.7(mL)-338.7(of)-330.5(st)15.1(re)19.7(pt)20.7(om)19.6(yc)19.7(in)20.7(,)-343.2(a)0(n)19.7(d)-346.7(25)]TJ
/F7 1 Tf
12.2912 0 TD
(m)Tj
/F3 1 Tf
.5414 0 TD
[(g/)20.7(mL)-338.7(of)-336.2(am)24.2(ph)15.1(o-)]TJ
-17.6189 -1.1116 TD
[(te)19.5(ri)20.7(ci)13.8(n)-513.7(B)-514.7(\(N)20(ac)18.5(al)19.5(ai)-504.6(Te)18.5(sq)15.3(ue)19.7(,)-510.3(I)0(n)15.1(c)0(.)23.1(\))-519.4(at)-504.6(37)]TJ
/F9 1 Tf
16.2136 0 TD
()Tj
/F3 1 Tf
.3859 0 TD
[(C)-514.7(i)0(n)-503.4(a)-514.9(hu)20.8(mi)19.5(di)15(e)19.8(d)]TJ
-16.5995 -1.1174 TD
[(at)19.5(mo)19.6(sp)21(he)13.9(re)-256.8(of)-261.4(5%)-262.4(CO)]TJ
7.3823 0 0 6.5614 149.2157 668.6927 Tm
(2)Tj
9.843 0 0 9.843 155.5653 670.3369 Tm
[(an)19.7(d)-271.8(9)0(5)20.8(%)-267.1(ai)19.5(r.)]TJ
/F8 1 Tf
8.9663 0 0 8.9663 62.022 648.3967 Tm
[(Hybridoma)-336.9(production)]TJ
/F3 1 Tf
9.843 0 0 9.843 72 631.9557 Tm
[(Female)-259(BALB/c)-265.5(mice)-255.8(\(4)-261.4(weeks)-256.2(old\))-257.9(were)-261(purchased)-260.8(from)]TJ
-1.0137 -1.1116 TD
[(CLEA)-411.9(Japan)-416.6(\(Tokyo,)-408.6(Japan\).)-415.3(Animals)-414.2(were)-410.7(housed)-410.8(under)]TJ
T*
[(specic)-252.9(pathogen-free)-260.9(conditions.)-252(The)-253.3(Animal)-252(Care)-255.4(and)-252.1(Use)]TJ
0 -1.1174 TD
[(Committee)-384.7(of)-382.3(Tohoku)-382.2(University)-381.8(approved)-385.5(the)-379(animal)-384.8(ex-)]TJ
0 -1.1116 TD
[(periments)-324.5(described)-318.6(herein.)-317.7(BALB/c)-323.1(mice)-319.1(were)-324.4(immunized)]TJ
T*
[(against)-401.8(the)-396.3(synthesized)-401.4(horse)-398.1(PDPN)-403.2(peptides)-397.1(\(horPP6279\))]TJ
T*
[(corresponding)-310.3(to)-313.3(amino)-307.5(acids)-313(6279)-305(of)-313.2(horse)-305.9(PDPN,)-314.5(which)]TJ
0 -1.1174 TD
[(were)-341.6(administered)-346.4(intraperitoneally)-346.6(\(i.p.\))-339.6(together)-345.4(with)-339.6(Im-)]TJ
0 -1.1116 TD
[(ject)-490.8(Alum)-490.4(\(Thermo)-495.1(Fisher)-491.3(Scientic,)-495(Inc.\).)-490.4(After)-491.4(several)]TJ
T*
[(additional)-347.9(immunizations,)-351.2(a)-347.8(booster)-342.8(injection)-352.6(was)-345(adminis-)]TJ
0 -1.1174 TD
[(tered)-457.2(i.p.)-458.4(2)-450.4(days)-460.4(before)-452.4(spleen)-458.1(cells)-457.1(were)-456.8(harves)-8.7(ted.)-451.5(The)]TJ
0 -1.1116 TD
[(spleen)-481.2(cells)-480.2(were)-479.9(fused)-478.7(with)-477.8(P3U1)-483.2(cells)-480.2(using)-477.7(PEG1500)]TJ
T*
[(\(Roche)-223(Diagnostics,)-231.9(Indianapolis,)-220.7(IN\).)-226.4(The)-224.5(hybridomas)-220.7(were)]TJ
0 -1.1174 TD
[(grown)-363.4(in)-359.4(RPMI)-363.3(medium)-361.7(supplemented)-363.6(with)-362.6(hypoxanthine,)]TJ
0 -1.1116 TD
[(aminopterin,)-491.8(and)-482.5(thymidine)-490.8(for)-487.1(selection)-491.7(\(Thermo)-483.5(Fisher)]TJ
T*
.0128 Tc
[(S)-5.4(c)-1(ie)-6.7(nt)-5.7(i)-5.4(c,)-428.4(I)-5.5(n).2(c)-6.7(.)-2.1(\).)-434.1(The)-433(c)-6.7(ul)-5.7(tur)-5.5(e)-433(su)-5.6(pe)-6.7(rn)-5.6(ata)-6.7(n).2(t)-5.7(s)-431.6(wer)-5.5(e)-433(sc)-6.7(re)-6.7(ene)-6.7(d)]TJ
0 -1.1174 TD
.0156 Tc
[(using)-469.3(e)1.8(nzyme-linked)-469.3(immuno)]TJ
12.7808 0 TD
.0154 Tc
[(sorbe)-4.1(n)2.8(t)-469.6(a)-4.1(ssay)-469.5(\(ELISA)-3.8(\))-469.5(f)2.8(or)]TJ
-12.7808 -1.1116 TD
0 Tc
[(assessing)-282.3(binding)-284.4(to)-278.8(horPP6279.)]TJ
/F8 1 Tf
8.9663 0 0 8.9663 62.022 423.7227 Tm
[(Enzyme-linked)-338.7(immunosorbent)-333.5(assay)]TJ
/F3 1 Tf
9.843 0 0 9.843 72 407.2818 Tm
[(The)-328.2(culture)-327(supernatants)-333.3(were)-330.1(screened)-330(using)-328(ELISA)-331.1(for)]TJ
-1.0137 -1.1116 TD
[(analyzing)-664.5(their)-657.7(binding)-664.6(to)-658.9(horPP6279,)-658.1(which)-658.5(was)-661.8(im-)]TJ
T*
[(mobilized)-330.6(on)-324.7(Nunc)-329(Maxisorp)-327.6(96-well)-326.8(immunopla)-8(tes)-326.9(\(Ther-)]TJ
0 -1.1174 TD
[(mo)-308.7(Fisher)-307(Scientic,)-316.4(Inc.\))-308.4(at)-308.8(1)]TJ
/F7 1 Tf
12.6253 0 TD
(m)Tj
/F3 1 Tf
.5472 0 TD
[(g/mL)-312.2(for)-308.5(30)-307.5(minutes.)-307.3(After)]TJ
-13.1724 -1.1116 TD
[(blocking)-545.9(nonspecic)-544.2(binding)-543.6(sites)-542.2(with)-541.2(SuperBlock)-544.2(T20)]TJ
T*
[(\(phosphate-buffered)-255.8(saline)-256.7([PBS]\))-249.1(Blocking)-253.2(Buffer)-250.6(\(Thermo)]TJ
0 -1.1174 TD
[(Fisher)-209.1(Scientic,)-207(Inc.\),)-202.4(the)-206.2(plates)-210.6(were)-203.4(incubated)-209.5(with)-207.1(culture)]TJ
0 -1.1116 TD
[(supernatant)-591.6(followed)-587(by)-583.9(incubation)-589.7(with)-581.5(1:1000)-588.5(diluted)]TJ
T*
[(peroxidase-conjugated)-439.2(anti-mouse)-435.1(IgG)-436.1(\(Agilent)-431.7(Technolo-)]TJ
T*
[(gies,)-440.9(Inc.,)-443.3(Santa)-445.5(Clara,)-444.4(CA\).)-440.6(The)-443.4(enzymatic)-448(reaction)-444.5(was)]TJ
0 -1.1174 TD
[(conducted)-606.8(with)-610.3(a)-607(1-Step)-606.7(Ultra)-606.8(TMB-ELISA)-609.3(instrument)]TJ
0 -1.1116 TD
[(\(Thermo)-391.4(Fisher)-387.7(Scientic,)-391.3(Inc.\).)-386.7(Optical)-391.4(density)-389.1(was)-385.3(mea-)]TJ
T*
[(sured)-294.4(at)-297.2(655)-164.6(nm)-291.4(using)-293.4(an)-297.1(iMark)-289.9(microplate)-298.3(reader)-298(\(Bio-Rad)]TJ
0 -1.1174 TD
[(Laboratories,)-286.3(Inc.,)-282(Berkeley,)-281.8(CA\).)]TJ
/F8 1 Tf
8.9663 0 0 8.9663 62.022 242.8724 Tm
[(Flow)-338.7(cytometry)]TJ
/F3 1 Tf
9.843 0 0 9.843 72 226.4315 Tm
[(Cells)-531.9(were)-537.5(harvested)-537.4(after)-532(a)-532.2(brief)-536.6(exposure)-535(to)-532.2(0.25%)]TJ
-1.0137 -1.1116 TD
[(trypsin/1)-171.3(mM)-349.9(EDTA)-354.1(\(Nacalai)-360.1(Tesque,)-353.2(Inc.\).)-358(After)-353.2(washing)]TJ
T*
[(with)-339.6(0.1%)-336.1(BSA/PBS,)-336.3(the)-338.7(cells)-336.2(were)-335.9(treated)-339.7(with)-339.6(a)-336.3(primary)]TJ
0 -1.1174 TD
[(mAb)-212.8(for)-210.6(30)-215.3(minutes)-211.8(at)-210.8(4)]TJ
/F9 1 Tf
9.6302 0 TD
()Tj
/F3 1 Tf
.3974 0 TD
[(C)-209.5(followed)-212.7(by)-215.3(treatment)-216.6(with)-212.9(Alexa)]TJ
-10.0276 -1.1116 TD
[(Fluor)-316.5(488-conjugated)-324.4(anti-mouse)-319.9(IgG)-320.9(\(1:1000;)-314.3(Cell)-323.6(Signal-)]TJ
T*
[(ing)-285.7(Technology,)-288.8(Inc.,)-287.8(Danvers,)-284.8(MA\).)-290.7(For)-285.3(the)-281.1(peptide)-292.5(block-)]TJ
T*
[(ing)-228.1(assay,)-235.5(cells)-232.5(were)-226.4(treated)-236.1(with)-230.2(PMab-202)-229.6(\(10)]TJ
/F7 1 Tf
19.3353 0 TD
(m)Tj
/F3 1 Tf
.5529 0 TD
[(g/mL\))-226.9(plus)]TJ
-19.8883 -1.1174 TD
[(peptides)-316.5(\(1)]TJ
/F7 1 Tf
4.6596 0 TD
(m)Tj
/F3 1 Tf
.5529 0 TD
[(g/mL\))-313.3(for)-314.3(30)-313.2(minutes)-315.4(at)-314.5(4)]TJ
/F9 1 Tf
10.6497 0 TD
()Tj
/F3 1 Tf
.3974 0 TD
[(C,)-310.8(followed)-316.3(by)-313.2(sec-)]TJ
-16.2596 -1.1116 TD
[(ondary)-405.2(antibodies.)-402.9(Fluorescenc)-10.8(e)-399.7(data)-404.3(were)-405(collected)-406.6(using)]TJ
T*
[(SA3800)-283.8(Cell)-283.3(Analyzers)-284.9(\(Sony)-276(Corporation,)-288.7(Tokyo,)-280.8(Japan\).)]TJ
/F8 1 Tf
8.9663 0 0 8.9663 62.022 105.9023 Tm
[(Western)-336(blot)-331.8(analysis)]TJ
/F3 1 Tf
9.843 0 0 9.843 72 89.4614 Tm
[(Cell)-456.1(lysates)-459.2(\(10)]TJ
/F7 1 Tf
6.8137 0 TD
(m)Tj
/F3 1 Tf
.5529 0 TD
[(g\))-451.4(were)-456.8(boiled)-457.3(in)-457.3(SDS)-453.1(sample)-459.4(buffer)]TJ
-8.3804 -1.1174 TD
[(\(Nacalai)-221.9(Tesque,)-226.5(Inc.\).)-219.7(The)-218.8(proteins)-223.1(were)-220.7(electrophoresed)-223.9(on)]TJ
0 -1.1116 TD
[(5%20%)-314(polyacrylamide)-315.4(gels)-316.5(\(FUJIFILM)-317.5(Wako)-313.1(Pure)-310.6(Che-)]TJ
T*
[(mical)-354.9(Corporation\))-355.4(and)-355.8(separated)-354.3(proteins)-355.6(were)-353.2(transferred)]TJ
25.504 67.9242 TD
[(onto)-338.6(a)-336.3(polyvinylidene)-340.8(diuoride)-339.5(membrane)-343(\()-81.7(Merck)-337(KGaA,)]TJ
0 -1.1174 TD
[(Darms)-8.6(tadt,)-429.7(Germany\).)-437.1(After)-433.8(blocking)-430.7(with)-431.8(4%)-435.2(skim)-431.8(milk)]TJ
0 -1.1116 TD
[(\(Naca)-9.8(lai)-413.7(Tesque,)-422.3(Inc.\),)-415.5(the)-419.3(membrane)-417.9(was)-419.8(incubated)-422.6(with)]TJ
T*
(1)Tj
/F7 1 Tf
.6681 0 TD
(m)Tj
/F3 1 Tf
.5529 0 TD
[(g/mL)-410.1(of)-411.1(PMab-202,)-411.6(and)-407.6(subsequently)-412.8(with)-414.5(peroxidase-)]TJ
-1.2211 -1.1116 TD
[(conjugated)-394.9(anti-mouse)-394.7(IgG)-390(\(1:1000)-387.9(diluted;)-390.6(Agilent)-390.3(Tech-)]TJ
0 -1.1174 TD
[(nologies,)-433.9(Inc.\).)-427.1(T)-19.6(h)-12.6(e)-445.8(i)-18.5(m)-13.8(m)-13.8(u)-18.4(n)-18.4(e)-440(r)-18.3(e)-19.5(a)-13.8(c)-19.5(t)-12.7(i)-18.5(o)-18.4(n)-438.8(w)-19.2(a)-13.8(s)-444.4(o)-18.4(b)-18.4(s)-12.4(e)-19.5(r)-12.6(v)-18.4(e)-19.5(d)-438.8(w)-19.2(i)-18.5(t)-12.7(h)]TJ
0 -1.1116 TD
-.0165 Tc
[(I)-34.8(m)-36.1(m)-30.3(u)-34.9(n)-29.1(o)-34.9(S)-29(t)-35(a)-36(r)-351.6(L)-30.3(D)-358.3(\()5.5(F)-.2(UJI)5.5(F)-.2(ILM)-323.8(W)3.2(ak)5.4(o)-322.9(P)-.2(u)5.4(r)-.3(e)-318.3(C)-1.3(hemical)-317.2(C)-1.3(or)5.5(por)5.5(a-)]TJ
T*
[(tion)5.5(\))-282.4(u)5.5(s)0(ing)-276.7(a)-277.8(Say)5.5(aca-Imager)-282.4(\()5.6(D)-1.1(RC)-277.7(Co)5.5(.)-279(L)-1.4(td)5.5(.,)-273.3(Tok)5.5(yo,)-279(J)5.7(a)-1.4(pan\).)]TJ
/F8 1 Tf
8.9663 0 0 8.9663 313.0582 621.014 Tm
0 Tc
[(Determination)-337.6(of)-336.7(the)-334.8(binding)-332.2(afnity)-334.4(using)-332.2(ow)]TJ
0 -1.2266 TD
(cytometry)Tj
/F3 1 Tf
9.843 0 0 9.843 323.0361 593.5746 Tm
[(CHO/horPDPN)-477.2(or)-474.5(FHK-Tcl3.1)-478.2(\(2)]TJ
/F9 1 Tf
14.4338 0 TD
()Tj
/F3 1 Tf
.72 0 TD
(10)Tj
7.3823 0 0 6.5614 482.003 597.9967 Tm
(5)Tj
9.843 0 0 9.843 490.3936 593.5746 Tm
[(cells\))-475.5(was)-471.7(sus-)]TJ
-18.0164 -1.1116 TD
[(pende)-7.8(d)-266(i)0(n)-273(100)]TJ
/F7 1 Tf
5.8864 0 TD
(m)Tj
/F3 1 Tf
.5529 0 TD
[(L)-273(o)0(f)-267.1(serial)-9(ly)-267.3(diluted)-274.2(PMab-202,)-273.3(followed)-270.3(by)]TJ
-6.4394 -1.1116 TD
[(addition)-563.3(of)-560.9(Alexa)-561.8(Fluor)-558.4(488-conjugated)-560.6(anti-mouse)-561.8(IgG)]TJ
T*
[(\(1:200)-6.7(;)-289.2(Cell)-294.8(Signaling)-293.5(Technology,)-294.6(Inc.\).)-288.8(Fluorescence)-301(data)]TJ
0 -1.1174 TD
[(were)-347.4(collected)-349(using)-345.3(EC800)-347.6(Cell)-340.9(Analyzer)-347.3(\(Sony)-345.1(Corpora-)]TJ
0 -1.1116 TD
[(tion\).)-331.7(The)-328.2(dissociation)-332.5(constants)-328.9(\()]TJ
/F10 1 Tf
13.8751 0 TD
(K)Tj
/F3 1 Tf
7.3823 0 0 6.5614 456.2078 537.1652 Tm
(D)Tj
9.843 0 0 9.843 461.4802 538.8093 Tm
[(\))-329.4(were)-330.1(obtained)-328.2(by)-324.7(t-)]TJ
-15.0789 -1.1116 TD
[(ting)-459.7(the)-453.9(binding)-451.5(isotherms)-455.6(using)-454.7(built-in)-458.5(one-site)-454.7(binding)]TJ
0 -1.1174 TD
[(models)-262.4(in)-261.5(GraphPad)-265.2(PRISM)-260.5(6)-260.3(\(GraphPad)-266.3(Software,)-263(Inc.,)-264.7(La)]TJ
0 -1.1116 TD
[(Jolla,)-286.6(CA\).)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 313.0582 478.4881 Tm
[(Results)-337.2(and)-331.9(Discussion)]TJ
/F3 1 Tf
9.843 0 0 9.843 323.0361 462.0471 Tm
[(Mice)-301.5(were)-301.3(immunized)-297.2(against)-303.8(horPP6279,)-295.2(corresponding)]TJ
-1.0137 -1.1116 TD
[(to)-313.4(amino)-307.5(acids)-307.3(6279)-310.8(of)-307.4(horse)-311.7(PDPN)-305.3(\(NCBI)-313.6(Reference)-310.5(Se-)]TJ
0 -1.1174 TD
[(quenc)-7.8(e:)-320.3(XM_014737713\).)-324.8(ELISA)-325.4(screening)-324.3(indicated)-330.6(posi-)]TJ
0 -1.1116 TD
[(tive)-391.7(signals)-388.9(in)-388.2(21)-388.1(out)-383.6(of)-388.1(960)-389.2(wells)-387.7(\(2.2%\).)-393.5(Among)-387.8(the)-384.7(21)]TJ
T*
[(wells,)-316.3(6)-312.1(wells)-318.6(\(29%\))-311.8(tested)-314.3(positive)-315.4(against)-315.4(CHO/horPDPN)]TJ
T*
[(in)-227(ow)-228.6(cytometry)-232.6(analysis.)-227.6(One)-230(clone)-226.8(among)-232.5(the)-223.5(six)-227.9(positive)]TJ
0 -1.1174 TD
[(clone)-8(s,)-217.4(namely,)-226.8(PMab-202)-223.8(\(IgG)]TJ
7.3823 0 0 6.5614 438.9731 394.6393 Tm
(1)Tj
9.843 0 0 9.843 442.6581 396.2834 Tm
[(,)-222.3(kappa\),)-225.4(was)-224(established)-222.9(by)]TJ
-13.1667 -1.1116 TD
[(limit)-7.3(ing)-279.9(dilution.)]TJ
1.0137 -1.1116 TD
[(PMab-202)-246.8(recognized)-246.2(horse)-242.6(PDPN)-247.7(in)-238.5(CHO/horPDPN)-252.6(and)]TJ
-1.0137 -1.1174 TD
[(did)-297.2(not)-291.4(react)-297.1(with)-293.5(CHO-K1)-298.2(cells)-295.9(in)-290.3(ow)-292(cytometry)-295.9(analysis)]TJ
0 -1.1116 TD
[(\(Fig.)-434(1A\).)-428(Furthermore,)-433.7(PMab-202)-436.9(reacted)-432.9(with)-431.7(the)-430.8(horse)]TJ
T*
[(kidney)-261.3(cell)-260.4(line)-253.5(FHK-Tcl3.1,)-262.7(indicating)-261.5(the)-258(ability)-257.1(of)-255.6(PMab-)]TJ
0 -1.1174 TD
[(202)-435.3(to)-434.3(recognize)-435.1(endogenous)-439.4(horse)-432.7(PDPN.)-435.5(PMab-202)-431.2(re-)]TJ
0 -1.1116 TD
[(acted)-446.9(with)-443.3(FHK-Tcl3.1)-443.6(cells)-445.6(in)-445.8(a)-440(dose-dependent)-446.2(manner)]TJ
T*
[(\(Fig.)-439.8(1B\).)-434(Flow)-437.2(cytometry)-439.9(was)-437.1(used)-437.3(to)-434.3(perform)-436.2(a)-434.2(kinetic)]TJ
T*
[(analy)-8(sis)-227.7(of)-226.8(the)-229.2(interaction)-235(of)-232.6(PMab-202)-229.6(with)-230.2(CHO/horPDPN)]TJ
0 -1.1174 TD
[(or)-578.1(FHK-Tcl3.1)-581.8(cells.)-581.5(The)-581.6(dissociation)-580.1(constant)-581.4(\()]TJ
/F10 1 Tf
21.3455 0 TD
(K)Tj
/F3 1 Tf
7.3823 0 0 6.5614 529.6818 285.0519 Tm
(D)Tj
9.843 0 0 9.843 535.0109 286.696 Tm
.577 Tc
[(\)o)577(f)]TJ
-22.5492 -1.1116 TD
0 Tc
[(PMab-202)-281.4(a)20.8(g)21.9(a)20.8(i)21.8(n)21.9(s)22.1(t)-237.4(C)20.9(H)21.1(O)21.1(/)21.8(h)21.9(o)21.9(r)22(P)22.1(D)21.1(P)22.1(N)-238.1(a)20.8(n)21.9(d)-231.5(F)22.1(H)21.1(K)21.1(-)22(T)20.7(c)20.8(l)21.8(3)21.9(.)19.6(1)-231.5(w)21.1(a)20.8(s)-237.1(d)21.9(e)20.8(t)21.8(e)20.8(r)22(-)]TJ
T*
.2876 Tc
[(m)308.3(i)309.4(n)309.5(e)308.4(dt)309.4(ob)309.5(e8)309.5(.)307.2(7)]TJ
/F9 1 Tf
6.3242 0 TD
0 Tc
()Tj
/F3 1 Tf
.6969 0 TD
-.0219 Tc
(10)Tj
/F9 1 Tf
7.3823 0 0 6.5614 391.5779 269.1779 Tm
0 Tc
(-)Tj
/F3 1 Tf
.5222 0 TD
(9)Tj
9.843 0 0 9.843 401.9526 264.8125 Tm
-.0228 Tc
[(M)-312.8(a)-2(nd)-311.9(2.1)]TJ
/F9 1 Tf
4.2161 0 TD
0 Tc
()Tj
/F3 1 Tf
.6969 0 TD
-.0219 Tc
(10)Tj
/F9 1 Tf
7.3823 0 0 6.5614 459.7227 269.1779 Tm
0 Tc
(-)Tj
/F3 1 Tf
.5222 0 TD
(6)Tj
9.843 0 0 9.843 470.0975 264.8125 Tm
-.0216 Tc
[(M,)-313(respectively,)-307.3(indi-)]TJ
-15.9544 -1.1174 TD
[(cating)-247.3(a)-242.7(moderate)-242.7(afnity)-247.3(of)-241.5(PMab-202)-247.3(toward)-241.6(CHO/horPDPN)]TJ
0 -1.1116 TD
[(and)-264.6(a)-260(very)-258.8(low)-259.7(a)-.8(fnity)-258.8(of)-264.6(PMab-202)-258.8(toward)-258.8(FHK-Tcl3.1.)]TJ
1.0137 -1.1116 TD
0 Tc
[(PMab-202)-350.5(was)-345(able)-346.7(to)-342.1(identify)-350.1(horse)-346.3(PDPN)-345.6(as)-343(a)-347.8(3)0(5)-169.2(kDa)]TJ
-1.0137 -1.1174 TD
[(band)-247.5(in)-250(FHK-Tcl3.1)-247.8(cells)-249.8(in)-250(Western)-248.4(blot)-246.6(analysis)-252.9(\(Fig.)-243.9(1C\).)]TJ
0 -1.1116 TD
[(This)-771.6(signal)-768.1(was)-771.2(blocked)-764.7(by)-768.2(horPP6279,)-767.5(but)-769.5(not)-763.7(by)]TJ
T*
[(horPP2336,)-260.7(which)-261.1(is)-261.3(corresponding)-264.2(to)-255.7(amino)-261.5(acids)-261.2(2336)-258.9(of)]TJ
0 -1.1174 TD
[(horse)-484.5(PDPN)-478.1(\(data)-480.2(not)-481.5(shown\),)-483(indicating)-480.4(that)-478.1(PMab-202)]TJ
0 -1.1116 TD
[(specically)-460.3(recognized)-453.5(horse)-449.9(PDPN.)-452.8(Furthermore,)-451(several)]TJ
T*
[(high-molec)-9(ular)-558.6(bands)-553.7(were)-560.5(observed)-563.8(at)-556.4(weak)-560.5(intensities)]TJ
T*
[(\(Fig.)-243.9(1C\).)-243.9(These)-250.7(bands)-242.6(were)-243.7(also)-247.4(blocked)-246.3(by)-238.3(horPP6279,)-249.1(but)]TJ
0 -1.1174 TD
[(not)-285.7(by)-284.4(horPP2336,)-289.5(suggesting)-282.8(that)-288.1(these)-290(bands)-282.9(might)-289.2(be)-279.8(ag-)]TJ
0 -1.1116 TD
[(gregation)-288.9(products)-280.6(of)-278.6(horse)-282.9(PDPN)-282.3(proteins.)]TJ
1.0137 -1.1116 TD
[(In)-509(ow)-510.9(cytometry,)-512.5(the)-505.7(PMab-202)-511.8(reaction)-513.6(with)-512.4(FHK-)]TJ
-1.0137 -1.1174 TD
[(Tcl3.1)-414.6(was)-414.1(blocked)-407.6(by)-411.1(horPP6279,)-410.4(but)-412.4(not)-412.4(by)-405.4(horPP2336)]TJ
0 -1.1116 TD
[(\(Fig.)-399.4(2\),)-403(also)-397.2(indicating)-405.5(that)-397.5(PMab-202)-402.4(specically)-402.7(recog-)]TJ
T*
[(nized)-284.4(horse)-282.9(PDPN.)]TJ
1.0137 -1.1174 TD
[(Taken)-371.9(together,)-377.7(PMab-202)-367.8(could)-375.4(prove)-369.5(useful)-370.5(for)-371.9(eluci-)]TJ
-1.0137 -1.1116 TD
[(dating)-572.5(the)-563.3(pathophysiological)-571(functions)-569.8(of)-566.6(horse)-565.1(PDPN.)]TJ
T*
[(Unfort)-7.6(unately,)-900.7(PMab-202)-909.2(was)-903.7(not)-901.9(found)-904(useful)-900.4(for)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 62.022 749.6502 Tm
(234)Tj
45.2847 0 TD
[(FURUSAWA)-335.2(ET)-338.7(AL.)]TJ
ET
endstream
endobj
32 0 obj
<>stream
q
1 i
154.772 756 m
454.847 756 l
454.847 285.902 l
154.772 285.902 l
W n
/GS1 gs
q
300.076 0 0 470.098 154.772 285.902 cm
/Im1 Do
Q
Q
/GS1 gs
BT
/F4 1 Tf
9.845 0 0 9.845 59.7543 269.1779 Tm
0 0 0 rg
0 Tc
0 Tw
[(FIG.)-354(1.)]TJ
/F3 1 Tf
4.1346 0 TD
[(Detection)-353.5(of)-353.3(horse)-351.5(PDPN)-350.8(by)-353.3(ow)-349.1(cytometry)-358.3(using)-350.5(PMab-202.)]TJ
/F4 1 Tf
26.0862 0 TD
(\(A\))Tj
/F3 1 Tf
1.7333 0 TD
[(CHO-K1,)-358.3(CHO/horPDPN,)-352.4(and)-349.7(FHK-Tcl3.1)]TJ
-31.9542 -1.0135 TD
[(cells)-272.4(were)-272(treated)-275.7(with)-270(PMab-202)-268.9(at)-268.2(a)-272.8(concentration)-271.4(of)-272.6(1)]TJ
/F7 1 Tf
23.1033 0 TD
(m)Tj
/F3 1 Tf
.5471 0 TD
[(g/mL)-271.4(\(dashed)-274(line\))-271.4(or)-266.9(control)-273.3(\(gray)-271(shade\))-267.2(for)-273.6(30)-266.9(minutes)-274.3(at)-268.2(4)]TJ
/F9 1 Tf
25.0785 0 TD
()Tj
/F3 1 Tf
.3973 0 TD
(C)Tj
-49.1261 -1.0135 TD
[(followed)-309.7(by)-301.4(the)-309.5(addition)-303.3(of)-307.2(secondary)-305.9(antibodies.)]TJ
/F4 1 Tf
20.4889 0 TD
(\(B\))Tj
/F3 1 Tf
1.6354 0 TD
[(FHK-Tcl3.1)-309.9(cells)-306.9(were)-306.6(treated)-304.5(with)-310.3(PMab-202)-303.4(at)-302.8(a)-307.4(concentration)-311.8(of)]TJ
-22.1243 -1.0135 TD
(1)Tj
/F7 1 Tf
.668 0 TD
(m)Tj
/F3 1 Tf
.5528 0 TD
[(g/mL)-282.9(\(dotted)-279.1(line\),)-286.3(10)]TJ
/F7 1 Tf
9.1215 0 TD
(m)Tj
/F3 1 Tf
.5528 0 TD
[(g/mL)-282.9(\(solid)-282.5(line\),)-280.5(and)-280.6(50)]TJ
/F7 1 Tf
10.2905 0 TD
(m)Tj
/F3 1 Tf
.5528 0 TD
[(g/mL)-277.1(\(dashed)-285.5(line\))-282.9(for)-279.4(30)-284.1(minutes)-280.1(at)-279.7(4)]TJ
/F9 1 Tf
15.669 0 TD
()Tj
/F3 1 Tf
.3973 0 TD
[(C)-278.4(followed)-286.7(by)-278.4(the)-280.7(addition)-286(of)]TJ
-37.8048 -1.0077 TD
[(secondary)-242.6(antibodies.)]TJ
/F4 1 Tf
8.9142 0 TD
(\(C\))Tj
/F3 1 Tf
1.6239 0 TD
[(Cell)-242.6(lysates)-239.6(of)-238.1(FHK-Tcl3.1)-240.8(\(10)]TJ
/F7 1 Tf
12.6112 0 TD
(m)Tj
/F3 1 Tf
.5471 0 TD
[(g\))-243.8(were)-237.5(electrophoresed)-245.5(and)-240.2(transferred)-239(onto)-240.2(a)-238.3(PVDF)-241.4(membrane.)]TJ
-23.6964 -1.0135 TD
[(The)-350.8(membrane)-347.8(was)-350.3(incubated)-346.8(with)-344.9(1)]TJ
/F7 1 Tf
15.4387 0 TD
(m)Tj
/F3 1 Tf
.5528 0 TD
[(g/mL)-346.2(of)-347.5(PMab-202)-349.5(and)-343.9(subsequently)-348.2(with)-350.6(peroxidase-conjugated)-350.6(anti-mouse)-347.6(IgG.)]TJ
-15.9915 -1.0135 TD
[(CHO,)-337.2(Chinese)-338.5(hamster)-332.9(ovary;)-335.5(PDPN,)-336.9(podoplanin;)-335.1(PVDF,)-331.1(polyvinylidene)-339.4(diuoride.)]TJ
ET
q
336.928 0 0 100.346 136.573 93.26 cm
/Im2 Do
Q
BT
/F4 1 Tf
9.845 0 0 9.845 59.7543 76.4787 Tm
[(FIG.)-302.2(2.)]TJ
/F3 1 Tf
4.077 0 TD
[(Blocking)-298.4(assay)-300.6(of)-295.7(PMab-202)-297.7(by)-301.4(horse)-293.9(PDPN)-298.9(peptide.)-300.9(PMab-202)-297.7(\(10)]TJ
/F7 1 Tf
28.1996 0 TD
(m)Tj
/F3 1 Tf
.5528 0 TD
[(g/mL\))-295.4(and)-297.8(horse)-299.6(peptides)-298.4(\(1)]TJ
/F7 1 Tf
11.6553 0 TD
(m)Tj
/F3 1 Tf
.5528 0 TD
[(g/mL\))-295.4(were)]TJ
-45.0376 -1.0077 TD
[(mixed)-306.9(\(dashed)-308.5(line\))-305.9(and)-303.6(allowed)-309.9(to)-301.6(react)-308.1(with)-304.6(FHK-Tcl3.1)-309.9(cells)-306.9(for)-302.4(30)-307.2(minutes)-303.1(at)-302.8(4)]TJ
/F9 1 Tf
34.2058 0 TD
()Tj
/F3 1 Tf
.3973 0 TD
[(C,)-304.8(followed)-309.7(by)-301.4(addition)-303.3(of)-307.2(secondary)]TJ
-34.6031 -1.0135 TD
[(antibodies.)-338.4(Gray)-334.2(shade,)-338.7(control)-330.9(\(without)-337.5(a)-330.4(primary)-337.7(mAb\).)]TJ
/F5 1 Tf
8.9663 0 0 8.9663 297.4109 34.2425 Tm
(235)Tj
ET
endstream
endobj
34 0 obj
<>stream
Adobe d C
q
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? Nycg?4ot{I|j1Y]bvJ(b'X%"G]V|ٳf͛6lٳf͘Nu9ĵɈo%SQd:[-)RCp*4l= ?[>sf2h1ԴiJ輷Z7f7?.=ɜ3? okRm&Ic9JBBg-EZdT5#TSۀ4N)Ξ;_;iX؊24duSѵЭ5k>ME.ERȖ
CAZtZ˫kګ mHXә٨+R &|ީGՖIVYUȪiHvQTbayF?2[=R,o#MǗ oٳf͛6lٳf~jIe̺2w.I$Ge cr[Ȗk^rΘaÕ[&gWꚝWpA&@7f͛6lٳf͛9科[kۘBUx+גU8~Bn6Ǩ-Hn-i@z7#_~`Ϛ 8Aa[/TiU"Ո9oHr<>/FOܵI#Ot([rE_F.]WDN4YX}KnAz18uem%I~$Xq%Ȧ 9]Y[ZJF~曜/WZK.SOUmQv9 B~ZG^CԮ'V-R
hz
EִoJմ#\Fjy:skoJv;,q#ay_z|aiŎ
n%^rZ
3f͛6lٳd_?C:ߘYͨ?q'_F\n{v bԵ_;:z39dR~g?(^Y9i u55 DOCΥ6lٳf͛6lMAz|p\zu{9Ok~Q[wSPJ]?*2ɂV̺ѵ-9s;qQ%X5O ?~N]id-t놆[pg; t@|N^_ *x
?U(G8m|?(5vGִL:}&Np(-v~~ΟhZ$["F)8p
yS4#?Ex|Q8-6g!UG!8EcN= )y`5A6os&Z %ye8!?'m:Ngf͛6lٳf͛6lo/%gumATOV# $ {&[ΞhtecFB/Fzc]/U4[{y!P{6lٳf͛6l_1 GyJzlZ Uqr놫1P(=sWYԴ0:yVa!TvG構 1 8~xX_<;TѾ3}jNOT}DmJI}'9avkPRSMM@jRi>ߕ\XfYiu